Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver

Apoptosis

Volumn 10, Issue 6, 2005, Pages 1261-1269

  Ben Ari, Z ^a   Mor, E ^a   Azarov, D ^a   Sulkes, J ^a   Tor, R ^a,b   Cheporko, Y ^b   Hochhauser, E ^b   Pappo, O ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Cathepsin B; Injury; Ischemia reperfusion; Liver; Rat

Indexed keywords

CATHEPSIN B; LIVER ENZYME;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME INACTIVATION; ENZYME INHIBITION; FLUOROMETRY; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; STATISTICAL SIGNIFICANCE;

ANIMALS; APOPTOSIS; CASPASE 3; CATHEPSIN B; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LIVER; MALE; MICE; MICE, INBRED C57BL; REPERFUSION INJURY;

ANIMALIA;

EID: 30944469449     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-2358-1     Document Type: Article

References (13)

1. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 2003; 125: 1246-1257.
2. Rudiger HA, Graf R, Clavien PA. Liver ischemia: Apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149-159.
3. Roberts LR, Kurosawa H, Bronk SF, et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 1997; 113: 1714-1726.
4. Jones B, Roberts PJ, Faubion WA, Kominami E, Gores GJ. Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol 1998; 275: G723-G730.
5. Guicciardi ME, Deussing J, Miyoshi H, et al. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 2000; 106: 1127-1137.
6. Guicciardi ME, Miyoshi H, Bronk SF, Gores GJ. Cathepsin B knockout mice are resistant to tumor necrosis factor-α-mediated hepatocyte apoptosis and liver injury. Am J Pathol 2001; 159: 2045-2054.
7. Canbay A, Guicciardi ME, Higuchi H, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152-159.
8. Selzner M, Rudiger HA, Selzner N, Thomas DW, Sindram D, Calvien PA. Bcl-2 overexpression in transgenic mice protects against ischemia & reperfusion injury of the liver. J Hepatol 2002; 36: 218-225.
9. Roberts LR, Adjei PN, Gores GJ. Cathepsin as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 1999; 30: 71-88.
10. Foghsgaard L, Wissing D, Manch D, et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 2001; 153: 999-1010.
11. Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol 2002; 283: G947-G956.
12. Werneburg NW, Guicciardi ME, Yin XM, Gores GJ. TNF-alpha-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent. Am J Physiol Gastrointes Liver Physiol 2004; 287: G436-G443.
13. Baskin-Bey ES, Canbay A, Bronk SF, et al. Cathepsin b inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia/warm reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2005; 283: G947-G956.